83036

Hemoglobin; glycosylated (A1C)

CPT code 83036 represents the laboratory test for glycosylated hemoglobin, commonly known as Hemoglobin A1c (HbA1c). This test measures the average blood glucose levels over the past two to three months by quantifying the percentage of hemoglobin that is bound to glucose. It provides a valuable long-term indicator of glycemic control, reflecting the chronic glucose exposure of red blood cells. The test is crucial for the diagnosis of diabetes mellitus, monitoring the effectiveness of diabetes management, and identifying individuals with prediabetes. It is typically performed on a venous blood sample using various analytical methods such as high-performance liquid chromatography (HPLC), immunoassay, or enzymatic assays.

Clinical Indications

  • Diagnosis of type 1 and type 2 diabetes mellitus in non-pregnant adults.
  • Monitoring long-term glycemic control in individuals with diagnosed diabetes mellitus (e.g., typically 2-4 times per year depending on stability and treatment changes).
  • Screening for prediabetes in at-risk individuals.
  • Assessing the effectiveness of lifestyle modifications or pharmacological interventions for diabetes.
  • Evaluating risk of developing diabetes-related complications.
  • Differentiating between short-term hyperglycemia and sustained elevated blood glucose levels.

Procedure Steps

  1. Collection of a venous blood sample, typically into an EDTA (lavender top) tube.
  2. Proper labeling and transportation of the blood specimen to the laboratory.
  3. Laboratory analysis of the blood sample using a validated method (e.g., HPLC, immunoassay, enzymatic assay) to quantify the percentage of glycosylated hemoglobin.
  4. Calculation and reporting of the HbA1c result, usually as a percentage.
  5. Interpretation of results by a healthcare provider in conjunction with clinical context.

Coding Guidelines

  • Report CPT code 83036 for the laboratory analysis of glycosylated hemoglobin (HbA1c).
  • Medical necessity must be documented to support the test. This typically includes a diagnosis of diabetes, prediabetes, or symptoms indicative of glucose dysregulation, or for monitoring established diabetes.
  • Frequency of testing should align with clinical guidelines (e.g., American Diabetes Association recommendations), typically 2-4 times per year for monitoring, or more frequently if glycemic control is unstable or treatment regimens change.
  • This code typically does not have global periods or significant bundling issues when performed as an individual laboratory test. However, it may be included in laboratory panels if applicable.
  • Ensure the documentation specifies the need for A1c measurement, not just general glucose testing.

Associated ICD-10 Codes